Literature DB >> 28280086

Phentermine induced acute interstitial nephritis.

Emily Ximin Shao1,2, Gregory John Wilson2, Dwarakanathan Ranganathan2.   

Abstract

Acute interstitial nephritis (AIN) has a number of medication-related aetiologies. Antibiotics, proton pump inhibitors and non-steroidal anti-inflammatory drugs are common causes; however, any medication has the potential to cause drug-induced AIN. We report the first case of phentermine-induced AIN. A Caucasian woman aged 43 years presented with a 5-week history of lethargy, left-sided lower abdominal pain, nausea and vomiting. She had been taking phentermine for weight loss for 9 months and had recently ceased the medication. The patient underwent a renal biopsy that showed a predominantly lymphohistiocytic interstitial infiltrate with a moderate number of eosinophils consistent with AIN. Phentermine is increasingly used for weight loss in obese patients. This is the first case implicating phentermine as the causative agent for drug-induced AIN. While rare, phentermine-induced AIN is a possible adverse reaction of phentermine. Physicians and patients need to be aware of this risk. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28280086      PMCID: PMC5353502          DOI: 10.1136/bcr-2017-219452

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis.

Authors:  A Schwarz; P H Krause; U Kunzendorf; F Keller; A Distler
Journal:  Clin Nephrol       Date:  2000-09       Impact factor: 0.975

2.  Acute interstitial nephritis: clinical features and response to corticosteroid therapy.

Authors:  Michael R Clarkson; Louise Giblin; Fionnuala P O'Connell; Patrick O'Kelly; Joseph J Walshe; Peter Conlon; Yvonne O'Meara; Anthony Dormon; Eileen Campbell; John Donohoe
Journal:  Nephrol Dial Transplant       Date:  2004-08-31       Impact factor: 5.992

3.  Increased prevalence of acute tubulointerstitial nephritis.

Authors:  Marian Goicoechea; Francisco Rivera; Juan M López-Gómez
Journal:  Nephrol Dial Transplant       Date:  2012-07-02       Impact factor: 5.992

Review 4.  Drug-induced acute interstitial nephritis.

Authors:  Mark A Perazella; Glen S Markowitz
Journal:  Nat Rev Nephrol       Date:  2010-06-01       Impact factor: 28.314

5.  Use of prescription antiobesity drugs in the United States.

Authors:  Christian Hampp; Elizabeth M Kang; Vicky Borders-Hemphill
Journal:  Pharmacotherapy       Date:  2013-09-09       Impact factor: 4.705

6.  Hypertension, end-stage renal disease and mesangiocapillary glomerulonephritis in methamphetamine users.

Authors:  E S W Jones; B L Rayner
Journal:  S Afr Med J       Date:  2015-03

7.  Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly.

Authors:  Angela K Muriithi; Nelson Leung; Anthony M Valeri; Lynn D Cornell; Sanjeev Sethi; Mary E Fidler; Samih H Nasr
Journal:  Kidney Int       Date:  2014-09-03       Impact factor: 10.612

8.  Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.

Authors:  Angela K Muriithi; Nelson Leung; Anthony M Valeri; Lynn D Cornell; Sanjeev Sethi; Mary E Fidler; Samih H Nasr
Journal:  Am J Kidney Dis       Date:  2014-06-11       Impact factor: 8.860

Review 9.  Methamphetamine and the expanding complications of amphetamines.

Authors:  T E Albertson; R W Derlet; B E Van Hoozen
Journal:  West J Med       Date:  1999-04

10.  Amphetamine-induced acute renal failure.

Authors:  R J Foley; K Kapatkin; R Verani; E J Weinman
Journal:  South Med J       Date:  1984-02       Impact factor: 0.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.